StockDuty Jun 18, 2026 06:38 PM ET
CatalystEarnings

$SRPT — SAREPTA THERAPEUTICS INC

SRPT
$16.85
+5.18%
$SRPT — SAREPTA THERAPEUTICS INC Q1: - Revenue: $731M - Adj EPS: $3.16 vs $1.05 🟢 - Adj operating margin: 49.0% (📈 +89.4pp YoY) Guidance: - FY revenue: $1.20B-$1.40B vs $1.84B est 🔴
Q1:
Sources
pipeline